CIP
PAHC icon

Chartwell Investment Partners’s Phibro Animal Health PAHC Stock Holding History

Chartwell Investment Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210,929
Closed -$4.04M – 429
2022
Q2 		$4.04M Sell
210,929
-2,297
-1% -$43.5K 0.16% 200
2022
Q1 		$4.25M Sell
213,226
-61,301
-22% -$1.24M 0.14% 216
2021
Q4 		$5.61M Sell
274,527
-5,170
-2% -$110K 0.16% 199
2021
Q3 		$6.03M Sell
279,697
-29,924
-10% -$720K 0.19% 193
2021
Q2 		$8.94M Sell
309,621
-3,274
-1% -$88.5K 0.26% 137
2021
Q1 		$7.63M Buy
312,895
+2,760
+0.9% +$62.3K 0.23% 160
2020
Q4 		$6.02M Sell
310,135
-3,946
-1% -$72.6K 0.19% 178
2020
Q3 		$5.46M Sell
314,081
-3,290
-1% -$70.2K 0.2% 171
2020
Q2 		$8.34M Buy
317,371
+14,305
+5% +$355K 0.32% 128
2020
Q1 		$7.33M Buy
303,066
+5,745
+2% +$140K 0.34% 114
2019
Q4 		$7.38M Buy
297,321
+2,150
+0.7% +$49.9K 0.24% 161
2019
Q3 		$6.3M Buy
295,171
+135,690
+85% +$3.72M 0.21% 182
2019
Q2 		$5.07M Buy
+159,481
New +$5M 0.17% 203

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chartwell Investment Partners's PAHC Position: Q3 2022 in Review

Chartwell Investment Partners sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 210,929 shares — an estimated $4.04M sold.

Chartwell Investment Partners first reported a position in PAHC in Q2 2019 and held it in 13 quarters. The position peaked at $8.94M in Q2 2021. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • Chartwell Investment Partners reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 210,929 Phibro Animal Health shares in Q3 2022, an estimated $4.04M.
  • Chartwell Investment Partners first reported a position in Phibro Animal Health in Q2 2019 and held it in 13 quarters.
  • Chartwell Investment Partners's Phibro Animal Health position peaked at $8.94M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on Chartwell Investment Partners's 13F filing for Q3 2022, filed 27 Oct 2022.